Martine Zimmermann, PharmD
Executive Vice President, Regulatory Affairs and Quality Assurance
Martine brings over 30 years of combined experience in R&D and global regulatory strategy. Most recently, she served as Senior Vice President, Head of Regulatory Affairs at Ipsen, where she successfully led the team that secured regulatory approvals for two liver disease therapies, including a dual PPARα/δ agonist for the treatment of primary biliary cholangitis.
Previously, Martine served as Senior Vice President and Head of Global Regulatory Affairs & Quality at Alexion Pharmaceuticals (now AstraZeneca Rare Disease) where she played a key role in advancing multiple orphan medicinal products globally. Earlier in her career, she held R&D and regulatory leadership positions at Aventis (now Sanofi), Servier, and H. Lundbeck A/S.
A recognized advocate for diversity, equity, inclusion, and belonging, Martine was honored as a Luminary by the Healthcare Businesswomen’s Association in 2020. She also served as an executive sponsor for Alexion’s flagship Women in Leadership (WIL) employee resource group. Martine earned her Doctor of Pharmacy (PharmD) from the University Louis Pasteur in Strasbourg, France.